|
MSF Field Research >
1 Published Research and Commentary >
Leishmaniasis/Kala Azar >
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India
Please use
this identifier to cite or link
to this item:
http://hdl.handle.net/10144/246593
 Del.icio.us
 LinkedIn
 Citeulike
 Connotea
 Facebook
 Stumble it!
| Title: | Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India |
| Authors: | Sinha, Prabhat K
van Griensven, Johan
Pandey, Krishna
Kumar, Nawin
Verma, Neena
Mahajan, Raman
Kumar, Pankaj
Kumar, Ranjeet
Das, Pradeeb
Mitra, Gaurab
Flevaud, Laurence
Ferreyra, Cecilia
Remartinez, Daniel
Pece, Manuel
Palma, Pedro Pablo |
| Affiliation: | Rajendra Memorial Research Institute of Medical Science, Patna, Bihar; Medecins Sans Frontieres–India, Operational Center Barcelona–Athens, New Delhi, India; Institute of Tropical Medicine, Antwerp, Belgium; Medecins Sans Frontieres, Medical Department, Operational Center Barcelona– Athens, Barcelona, Spain |
| Citation: | Clin Infect Dis 2011; 53(7):e91-e98 |
| Publisher: | Oxford University Press |
| Journal: | Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America |
| Issue Date: | Oct-2011 |
| URI: | http://hdl.handle.net/10144/246593 |
| DOI: | 10.1093/cid/cir521 |
| PubMed ID: | 21890763 |
| Additional Links: | http://cid.oxfordjournals.org/content/53/7/e91.abstract |
| Abstract: | Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection. We report the 2-year treatment outcomes of VL-HIV-coinfected patients treated with liposomal amphotericin B followed by combination antiretroviral treatment (cART) in Bihar, India. |
| Type: | Article |
| Language: | en |
| MeSH: | Adolescent
Adult
Amphotericin B
Anti-HIV Agents
Antifungal Agents
Antiretroviral Therapy, Highly Active
Female
HIV Infections
Humans
India
Leishmaniasis, Visceral
Male
Recurrence
Survival Analysis
Treatment Failure
Treatment Outcome |
| ISSN: | 1537-6591 |
| Rights: | Archived with thanks to Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| Appears in topics: | Leishmaniasis/Kala Azar
|
| Related articles on PubMed | | | |  | Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.Molina I, Falcó V, Crespo M, Riera C, Ribera E, Curran A, Carrio J, Diaz M, Villar del Saz S, Fisa R, López-Chejade P, Ocaña I, Pahissa A 2007 Oct |
| | | See all 155 articles |
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.
|
